CAPITAL MARKET OPERATIONS
Lexelians Avocats lawyers have recognized expertise in capital markets. The team is made up of Laurent Beauvoit, Jonathan Santoro and Romain Guez. We advise listed companies and investment banks on the following transactions:
- Initial public offerings (Euronext, Growth, Access)
- Securities offerings through public offerings and private placements: capital increases, issues of structured products (e.g. convertible bonds, bonds convertible into new or existing shares, bond redeemable in cash and shares), equity line,
- Debt restructuring
- Investment in listed companies : threshold crossing and declarations of intent, control issues, other reporting obligations, prevention of market abuse;
- Mergers, spin-off, contributions
- Friendly or unsolicited tender offers (purchase, exchange, squeeze-out), public shares buy-back offers, delisting, takeover strategies (concerted action), anti-tender offer defense;
- Block trades, etc.
- Governance: governance charters, best practices, directors' responsibilities.
For the fifth year running, Lexelians Avocats has been ranked as one of the "must-see" firms for "DCM & ECM Small to Mid-Cap" operations in the October 2024 ranking published by Décideurs - Leaders League magazine.
Laurent Beauvoit and his team have been involved in over two hundred financial operations, including IPOs (EDF, Horizontal Software, Predilife, Pherecydes Pharma, AMA, Toosla...), capital increases (Société Générale, France Telecom, Veolia Environnement, Rhodia, Eurobio Scientific ...), complex securities issues (convertibles, bond redeemable in cash and shares, bonds convertible into new or existing shares, bonds convertible into shares with attached shares warrants ... by Business Objects, Altran, Publicis, Eurobio Scientific ...), tender offers/exchange public offers/ public shares buy-back offers (Grand Marnier, Business Objects, Infogrames, Aurea, Horizontal Software, Hiolle Industrie ...) and bond issues (Aurea, Infogrames, Rhodia, CMA-CGM ...).
Our latest operations
Initial public offerings, listings
Toosla
IPO on Euronext Growth Paris ( €6.2M )
December 2021
Deal counsel
AMA Corporation
IPO on Euronext Growth
( 36M € )
June 2021
French board of the issuer
Beaconsmind
IPO on Euronext Access+ Paris ( €2.5M )
February 2021
Deal Counsel
Pherecydes Pharma
IPO on Euronext Growth
( 8M € )
February 2021
Deal Counsel
Entech
IPO on Euronext Growth Paris ( €25M )
September 2021
Counsel of shareholder funds
Media Maker
Private placement listing on Euronext Access Paris ( € 2.5M )
July 2019
Corporate and stock market consulting
Predilife
IPO on Euronext Growth
( 2.6M € )
December 2018
Deal counsel
Parx Plastics
Private placement listing on Euronext Access Paris
May 2018
Corporate and stock market advisory
Medialab
Private placement listing on Euronext Access Paris
March 2018
Corporate and stock market advisory
Gour Medical
Private placement listing on Euronext Access Paris
December 2016
Corporate and stock market advisory services
Horizontal Software
IPO on Euronext Growth Paris ( € 6M )
December 2016
Deal counsel
Orclass
Private placement listing on Euronext Access Paris
November 2014
Corporate board
Groupe Concourmania
IPO on Euronext Growth Paris ( € 9.2M )
May 2011
Deal counsel
Capital increase (private placements and public offerings)
Nicox
Disposal of intellectual property rights and issue of ABSA by private placement ($16.5 M)
October 2024
Corporate and stock market advisory services
Nicox
Capital increase with pre-emptive rights (€3.3m)
June 2024
Board of Directors
ST Dupont
Capital increase with preferential subscription rights ( €25M )
February 2024
Corporate and securities law counsel of the Company
AMA
Issuance of shares by public offering ( € 8M )
June 2023
Counsel of the company
Theraclion
Issuance of ABSA by private placement and public offering ( €12.7M )
June 2023
Counsel of the company
Toosla
Issuance of shares by private placement and public offering
( 3,6M € )
March 2023
Board of Directors
Abivax
Private placement share issue
( 180M € )
February 2023
Corporate Investors Council
Metavisio Thomson
Issuance of shares by private placement and public offering
( 3,6M € )
November 2022
Board of Directors
Abivax
Private placement share issue ( €49M )
September 2022
Corporate counsel of investors
Visiomed
Private placement share issue
( 1,7M € )
May 2022
Corporate and stock market advisor
Theraclion
Private placement share issue
( 6,5M € )
March 2022
Corporate and securities law counsel of the Company
Visiomed
Private placement share issue
( 3,2M € )
March 2022
Corporate and securities law counsel of the Company
Visiomed
Private placement share issue ( €2M )
September 2021
Corporate and stock market advisory services
Visiomed
Private placement share issue ( €2M )
January 2021
Corporate and stock market advisory services
Predilife
Public offering of shares
( 2M € )
December 2020
Corporate and stock market advice to the issuer
Horizontal Software
Issue reserved for named persons
( 4,5M € )
April 2020
Corporate and stock market advisory services
Hybrigenics Pharma
Equity line (€4M)
November 2019
Corporate and stock market advisory services
Gour Medical
Private placement
September 2019
Corporate and stock market consulting
Theraclion
Private placement of shares and OCAs
( 4.8M € )
March 2019
Corporate and stock market consulting
Eurobio Scientific
Private placement share issue ( €3M )
March 2019
Corporate and stock market consulting
Eduniversal
Private placement
March 2019
Corporate and stock market consulting
Horizontal Software
Private placement share issue ( €3M )
March 2019
Corporate and stock market consulting
Gour Medical
Private placement
February 2019
Corporate and stock market consulting
Horizontal Software
Private placement share issue ( €1.3M )
February 2018
Corporate and stock market advisory
Theraclion
Private placement share issue
( 4,2M € )
October 2017
Corporate and stock market advisory
Eurobio Scientific
Public offering of shares
( 28,9M € )
February 2017
Corporate and stock market advisory
Theraclion
Capital increase with preferential subscription rights ( € 10M )
August 2016
Corporate and stock market advisory
Theraclion
Private placement share issue ( €1.8M )
May 2016
Corporate and stock market advisory services
Eurobio Scientific
Issuance of shares reserved for a category of persons (TEPA law)
November 2015
Corporate and stock market consulting
Theraclion
Private placement share issue ( €4M )
June 2015
Corporate and stock market consulting
Eurobio Scientific
Issuance of shares reserved for a category of persons (TEPA law)
May 2015
Corporate and stock market advisory services
Eurobio Scientific
Issuance of shares reserved for a category of persons (TEPA law)
May 2014
Corporate and stock market advisory services
Issues of composite securities, equity lines, bonds
Plant Advanced Technologies
ORA issue ( 1M€ )
February 2024
Issuer's board
Hybrigenics
OCA issue ( €1.5M )
October 2023
Issuer's Board
Versity
Issue of shares, warrants and convertible bonds ( €19.6M )
May 2023
Board of Directors
Abionyx
OCA issue ( €12M )
May 2023
Counsel of the investor
Poxel
Issue of BEORA
( 20M € )
March 2023
Investor tip
Cibox
Equity line BEORA
( 2M € )
December 2022
Investor tip
Poxel
OCA issue ( €6M )
August 2022
Investor advice
Energisme
Equity line OCABSA
( 12M € )
July 2022
Issuer's Board
Hopium
Equity Line ( € 50M )
June 2022
Investor advice
Energisme
Equity line BEORA
( 10M € )
January 2022
Investor tip
Cibox Inter@ctive
Equity line BEORA
( 1,5M € )
July 2021
Investor advice
Boostheat
Issue of BEORA
( 10M € )
May 2021
Issuer's Board
Auplata Mining Group
Private placement issue of ORABSA ( €50M )
May 2021
Deal Counsel
Hybrigenics
NRS private placement issue ( €50M )
March 2021
Deal Counsel
Visiomed Group
OCABSA private placement issue
( 180M € )
February 2021
Issuer's Board
Cerinnov Group
Equity line ( € 2M )
December 2020
Investor's Council
Visiomed Group
Equity line ( € 20M )
February 2021
Corporate and stock market advice to the issuer
DBT
BSA issue ( €20M )
November 2020
Corporate and stock market advice to the issuer
Theranexus
Equity line ( € 4.2M )
July 2020
Corporate and stock market advice to the investor
Santhera
Equity Line ( CHF 12M )
April 2020
Corporate and stock market advice for investors
Vergnet
Equity line ( 1M € )
February 2020
Corporate and stock market advice for investors
DMS Group
ORNANE issue
( 4M € )
December 2019
Investor advice
Novacyt Group
Equity line ( € 5M )
April 2019
Investor advice
Theraclion
Private placement of shares and OCAs
( 4.8M € )
March 2019
Corporate and stock market consulting
GECI International
ORNANE issue
( 4M € )
February 2019
Corporate and stock market consulting
Horizontal Software
Issue of OCEANE bonds with warrants ( € 2M )
July 2018
Corporate and stock market advisory
Aurea
Bond issue ( € 5M )
June 2018
Corporate and stock market advisory
Theraclion
Equity line ( 3.6M € )
July 2018
Corporate and stock market advisory
Vergnet Group
Equity line ( 2 tranches of 2M € )
May 2018
Corporate and stock market advisory
Sepimo
OCA issue ( € 5M )
February 2018
Corporate counsel of the company.
GECI International
ORNANE issue
( 9M € )
July 2017
Corporate and stock market advisory
SCBSM
ORNANE issue
( 20M € )
May 2017
Corporate and stock market advisory
Theraclion
Equity line ( 3M € )
March 2015
Corporate and stock market advisory services
Eurobio Scientific
Issue of OCABSA
( 10M € )
June 2014
Corporate and stock market consulting
Aurea
Bond issue ( €13.6M )
June 2013
Corporate and stock market consulting
Offers (tender offers, exchange offers, public buy-in offers and squeeze-out)
Groupe Hiolle Industries
Takeover bid by Hiolle Développement and squeeze-out ( €5.45M )
July 2022
Corporate and stock market consulting
Horizontal Software
Takeover bid by Extens and squeeze-out
December 2020.
Corporate and stock market consulting
Aurea
Public share buyback offer ( €15M )
October 2019
Deal counsel
Grand Marnier
Takeover bid initiated by Campari
( 680M € )
May 2016
Grand Marnier Stock Exchange Council
Parot Group
Takeover bid by NDK and squeeze-out (€51m)
October 2024
NDK's stock market advice
Mergers, spin-off, contributions, universal transfer of assets and liabilities
The Azur Selection
Acquisition of 100% of the capital of HOTELS DU GROUPE BOUCAU
February 2024
Purchaser's advice
Hybrigenics
Hybrigenics acquires majority stake in Inoviem
May 2021
Hybrigenics Board
Artéa Groupe
Sale of a block of off-market shares
( 5.4M € )
February 2020
Deal counsel
Horizontal Software
Universal transfer of assets and liabilities of Tehems, LPDR, Formaeve and Equitime
June 2019
Group Corporate Council
Eurobio Scientific
Contribution in kind for the acquisition of Pathway Diagnostics
( 1M € )
June 2019
Corporate and stock market advisory services
Eurobio Scientific
Universal transfer of Eurobio's assets and liabilities
December 2018
Group Corporate Council
Horizontal Software
Contribution in kind in connection with the acquisition of Formaeva
December 2017
Corporate and stock market advisory
Eurobio Scientific
Universal transfer of assets and liabilities of Eurobio and Ingen
December 2017
Group Corporate Council
Eurobio Scientific
Contribution in kind for the acquisition of Capforce Plus ( €18.8M )
March 2017
Corporate and stock market advisory
Eurobio Scientific
Universal transfer of assets and liabilities of Ingen Biosciences and Ingen
December 2013
Group Corporate Council
Eurobio Scientific
Contribution in kind for the acquisition of Ingen Biosciences
( 10M € )
December 2012
Corporate and stock market advisory services
Contact
11 avenue de l'Opéra
75001
Paris
16 avenue Foch
06000
Nice
16 bis Quai Amiral Hamelin
14000
Caen
Site design and referencing by
